SCHEMBL25925873

SCHEMBL25925873

COc1cc(/N=N/c2ccnn2C)c(O)c(/N=N/c2ccnn2C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.36
MAPT P10636 4/20 0.36
HSP90AA1 P07900 3/20 0.36
MAPK1 P28482 3/20 0.36
OPRK1 P41145 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
NPC1 O15118 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
POLB P06746 2/20 0.34
KCNH2 Q12809 1/20 0.34
CYP3A4 P08684 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGDS O60760 2/20 0.32
AHR P35869 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925924 0.86 RAB9A (0.46) RAB9AMAPTHSP90AA1MAPK1OPRK1
SCHEMBL25925897 0.85 PTGS2 (0.51) RAB9AMAPTATMNPC1L3MBTL1
SCHEMBL25925876 0.83 KMT2A (0.33) RAB9AHSP90AA1MAPK1OPRK1NPC1
SCHEMBL25925880 0.82 MAPT (0.33) RAB9AMAPTHSP90AA1MAPK1OPRK1
SCHEMBL25925862 0.78 MAPT (0.34) RAB9AMAPTHSP90AA1MAPK1KDM4E
SCHEMBL25925882 0.78 AHR (0.36) RAB9AMAPTHSP90AA1MAPK1OPRK1
SCHEMBL25925911 0.73 EGFR (0.49) RAB9AMAPTMAPK1KDM4ENPC1
SCHEMBL25925733 0.72 ALDH1A1 (0.36) MAPTALDH1A1
SCHEMBL25925704 0.72 MAPT (0.33) RAB9AMAPTHSP90AA1MAPK1OPRK1
SCHEMBL25925933 0.71 PTGS1 (0.41) RAB9AMAPTHSP90AA1MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 RAB9A 1490/4885MAPT 2/4885HSP90AA1 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.